Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | HCRTR2 | O43614 | 6/20 | 0.46 |
| ▸ | HCRTR1 | O43613 | 5/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | PORCN | Q9H237 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13272509 | 0.95 | TRPV1 (0.45) | TRPV1HCRTR2HCRTR1CYP2C9CYP2C19 | |
| SCHEMBL845841 | 0.95 | TRPV1 (0.45) | TRPV1HCRTR2HCRTR1CYP2C9CYP2C19 | |
| SCHEMBL845349 | 0.91 | HCRTR1 (0.53) | TRPV1HCRTR2HCRTR1CYP2C9CYP2C19 | |
| SCHEMBL845699 | 0.88 | RHOC (0.48) | HCRTR1DGAT1HTT | |
| SCHEMBL845114 | 0.85 | EP300 (0.46) | TRPV1DGAT1ALDH1A1HTT | |
| SCHEMBL845640 | 0.85 | ALDH1A1 (0.49) | TRPV1HCRTR2HCRTR1ROCK2ALDH1A1 | |
| SCHEMBL845651 | 0.85 | CYP2C9 (0.43) | TRPV1CYP2C9CYP2C19ROCK2DGAT1 | |
| SCHEMBL10119343 | 0.84 | ALDH1A1 (0.44) | HCRTR2CYP2C9CYP2C19ROCK2DGAT1 | |
| SCHEMBL10119346 | 0.84 | RHOC (0.45) | HCRTR2HCRTR1DGAT1ALDH1A1 | |
| SCHEMBL13272491 | 0.83 | TRPV1 (0.38) | TRPV1HCRTR2HCRTR1CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |